Please select the option that best describes you:

How would you treat oligometastatic NSCLC (brain and bone) with Non-V600E BRAF mutations?   

SRS done to the single brain met, PD-L1 5%,  BRAF G469A mutation



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more